Sfoglia per AUTORE
MOSCONI S
Collezione AO Ordine Mauriziano

  

Items : 5

Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants. in Cancer medicine / Cancer Med. 2025 Feb;14(3):e70364. doi: 10.1002/cam4.70364.

2025
AO Ordine Mauriziano
AOU Novara

Bencardino K; Forti L; Spallanzani A; Paratore C; Bernardini I; Giommoni E; Mosconi S; Scartozzi M; Rodriquenz MG; Rapposelli IG; Niger M; Bittoni A; Palloni A; Carloni R; Bergamo F; Chiaravalli M; Gaule M; Cavaliere A; Macchini M; Giordano G; Vasile E; Garajova I; Bozzarelli S; Noventa S; Procaccio L; Salvatore L; di Marco M; Orsi G; Milella M; et alii...

Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study. in BMC cancer / BMC Cancer. 2024 May 6;24(1):563. doi: 10.1186/s12885-024-12328-0.

2024
AO Ordine Mauriziano

Niger M; Nichetti F; Fornaro L; Pircher C; Morano F; Palermo F; Rimassa L; Pressiani T; Berardi R; Gardini AC; Sperti E; Salvatore L; Melisi D; Bergamo F; Siena S; Mosconi S; Longarini R; Arcangeli G; Corallo S; Delliponti L; Tamberi S; Fea E; Brandi G; Rapposelli IG; Salati M; Baili P; Miceli R; Ljevar S; Cavallo I; et alii...

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study. in BMC cancer / BMC Cancer. 2024 Apr 8;24(1):436. doi: 10.1186/s12885-024-12225-6.

2024
AO Ordine Mauriziano

Niger M; Nichetti F; Fornaro L; Pircher C; Morano F; Palermo F; Rimassa L; Pressiani T; Berardi R; Gardini AC; Sperti E; Salvatore L; Melisi D; Bergamo F; Siena S; Mosconi S; Longarini R; Arcangeli G; Corallo S; Delliponti L; Tamberi S; Fea E; Brandi G; Rapposelli IG; Salati M; Baili P; Miceli R; Ljevar S; Cavallo I; et alii...

Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey. in ESMO open / ESMO Open. 2021 Oct;6(5):100238. doi: 10.1016/j.esmoop.2021.100238. Epub 2021 Aug 13.

2021
AO Ordine Mauriziano
AOU Novara

Reni M; Milella M; Cascinu S; Militello AM; Valente MM; Forti L; Scartozzi M; Giommoni E; Macchini M; Tamburini E; Bencardino K; Mosconi S; Spallanzani A; Paratore C; Bernardini I; Peretti U; Penzo E; De Lorenzo S; Rodriquenz MG; Bittoni A; Garajova I; Tortora G; Rapposelli IG; Giordano G; Noventa S; Bozzarelli S; Niger M; Cavaliere A; Di Marco M; et alii...

Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2020 Mar 1;26(5):1017-1024. doi: 10.1158/1078-0432.CCR-19-3024. Epub 2019 Nov 18.

2020
AO Ordine Mauriziano

Milione M; Di Nicolantonio F; Tamborini E; Perrone F; Barault L; Macagno M; Martinetti A; Palermo F; Guarini V; Pagani F; Corallo S; Randon G; Gori S; Petrelli F; Farina G; Longarini R; Tomasello G; Sartore-Bianchi A; Murgioni S; Rimassa L; Mosconi S; Morano F; Raimondi A; Lonardi S; Antista M; Lobefaro R; Pietrantonio F; Di Maio M; Fucà G; et alii...